Recent efforts by the federal government to develop a strategy for guiding (and regulating) the use of artificial intelligence (AI) have targeted multiple industry sectors, with healthcare at the forefront. For example, under the President’s recent executive order, in 2024 the Department of Health and Human Services is required to educate itself, publish guidance, and develop a strategy to potentially regulate the development and use of AI within its areas of oversight. Congress, in comparison, is taking a more measured approach, and its future involvement in AI regulation remains unclear.
We discuss the recent federal executive and legislative efforts in the United States and their potential impact for companies that use AI in the health sector in a Reed Smith in depth perspective article.
Reed Smith will continue to follow developments related to the regulation of AI in the health care sector. If you have any questions, please reach out to the authors or to the health care lawyers at Reed Smith.